Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gilbert MR"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 61
Tytuł:
Clinical outcome assessment trends in clinical trials-Contrasting oncology and non-oncology trials.
Autorzy:
Kim Y; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 16945-16957. Date of Electronic Publication: 2023 Jul 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Neoplasms*/therapy
Humans ; Medical Oncology ; Outcome Assessment, Health Care ; Research Design ; Clinical Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma.
Autorzy:
Amin N; National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.
Wang H; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Song Q; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Bhaskar M; Translational Neuroscience Center, National Institutes of Health, Bethesda, MD 20892, USA.
Yadav SP; Vaxess Technologies, Woburn, MA 02139, USA.
Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pant H; National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.
Tabouret E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.; Institute of NeuroPhysiopathology (INP), National Centre for Scientific Research (CNRS), Aix-Marseille University, 13005 Marseille, France.
Zhuang Z; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 21; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 21.
Typ publikacji:
Journal Article
MeSH Terms:
Cyclin-Dependent Kinase 5*/metabolism
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Mice ; Humans ; Animals ; Irinotecan/pharmacology ; Irinotecan/therapeutic use ; Apoptosis ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; G2 Phase Cell Cycle Checkpoints
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial.
Autorzy:
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. .
Acquaye-Mallory AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Mendoza T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Stockdill ML; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 21; Vol. 23 (1), pp. 262. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Virtual Reality Exposure Therapy*/methods
Brain Neoplasms*/therapy
Humans ; Feasibility Studies ; Anxiety/etiology ; Anxiety/therapy ; Anxiety Disorders ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Probabilistic model checking of cancer metabolism.
Autorzy:
Friedenberg MD; Cornell University, Ithaca, NY, 14850, USA.
Lita A; National Cancer Institute, Bethesda, MD, 20892, USA.
Gilbert MR; National Cancer Institute, Bethesda, MD, 20892, USA.
Larion M; National Cancer Institute, Bethesda, MD, 20892, USA.
Celiku O; National Cancer Institute, Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 07; Vol. 12 (1), pp. 18870. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
MeSH Terms:
Glutamine*/metabolism
Neoplasms*/genetics
Neoplasms*/metabolism
Humans ; Models, Statistical ; Cell Hypoxia ; Glucose/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model.
Autorzy:
Shuboni-Mulligan DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
Young D Jr; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
De La Cruz Minyety J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Munasinghe J; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, NIH, Bethesda, MD, USA.
Wang H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Adegbesan KA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Smart DK; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 01; Vol. 12 (1), pp. 11131. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Circadian Rhythm*/physiology
Disorders of Excessive Somnolence*
Animals ; Brain ; Disease Models, Animal ; Mice ; Sleep/physiology ; Suprachiasmatic Nucleus/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.
Autorzy:
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Shuboni-Mulligan DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Crandon S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Christ A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Jammula V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Theeler B; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Wall K; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Jun 22; Vol. 9 (6), pp. 526-535. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.
Autorzy:
Jammula V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Rogers JL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Christ A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Levine JE; Office of Information Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lindsley M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Timmer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boris L; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Panzer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Smith-Cohn MA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pillai V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 May 14; Vol. 9 (5), pp. 429-440. Date of Electronic Publication: 2022 May 14 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients.
Autorzy:
Shah AH; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA. .
Govindarajan V; Department of Neurosurgery, University of Miami School of Medicine, Miami, FL, USA.
Doucet-O'Hare TT; Center for Cancer Research (CCR), National Institutes of Health, National Cancer Institute (NCI), Neuro-Oncology Branch (NOB), Bethesda, MD, USA.
Rivas S; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Ampie L; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
DeMarino C; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Banasavadi-Siddegowda YK; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Zhang Y; Bioinformatics Section, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Johnson KR; Bioinformatics Section, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Almsned F; Bioinformatics Section, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Gilbert MR; Center for Cancer Research (CCR), National Institutes of Health, National Cancer Institute (NCI), Neuro-Oncology Branch (NOB), Bethesda, MD, USA.
Heiss JD; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Nath A; Surgical Neurology Branch, National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Apr 27; Vol. 12 (1), pp. 6902. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Endogenous Retroviruses*/genetics
Glioblastoma*/genetics
Computational Biology ; DNA Methylation ; Humans ; Open Reading Frames
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeting selenoprotein H in the nucleolus suppresses tumors and metastases by Isovalerylspiramycin I.
Autorzy:
Cui J; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Zhou J; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
He W; CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking, 100050, China.
Ye J; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Westlake T; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Medina R; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Wang H; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Thakur BL; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Liu J; CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking, 100050, China.
Xia M; School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, China.
He Z; Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, China.
Indig FE; Confocal Imaging Facility, National Institute On Aging, National Institutes of Health, Baltimore, MD, 21224, USA.
Li A; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Li Y; Basic Neurosciences Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA.
Weil RJ; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Aladjem MI; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Zhong L; College of Stomatology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA.
Zhuang Z; Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Building 35 Room 2B203 35 Convent Dr., Bethesda, MD, 20892, USA. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Apr 06; Vol. 41 (1), pp. 126. Date of Electronic Publication: 2022 Apr 06.
Typ publikacji:
Journal Article
MeSH Terms:
Cell Nucleolus*/metabolism
RNA, Ribosomal*/metabolism
Genomic Instability ; Humans ; Nuclear Proteins/metabolism ; Reactive Oxygen Species/metabolism ; Selenoproteins/genetics ; Selenoproteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 61

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies